Publications by authors named "Christina Hart"

Claim this Profile
S
Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A.
Inga M Schimansky, Christiane Dobbelstein, Robert Klamroth, Christina Hart, Ulrich J Sachs

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxis.
Fabius J Pelzer, Ella I Ertekin, Olga Oleshko, Annika Klingberg, Paul Knöbl, Christina Hart

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of the API-CAT Trial for Extended Secondary Prophylaxis of Cancer-associated Venous Thromboembolism: Guidance from an Expert Panel.
Florian Langer, Christina Hart, Kai-Michael Klima, Sandra Marten, Katja S Mühlberg

Hamostaseologie· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet lipidomics indicates enhanced thrombocyte activation in patients with antiphospholipid syndrome in vivo.
Susanne Heimerl, Marcus Höring, Ralph Burkhardt, Matthias Höpting, Alexander Sigruener, Christina Hart

J Thromb Haemost· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Prevention of Cancer-Associated Thrombosis: Current Perspectives.
Christina Hart, Nick van Es, Minna Voigtlaender

Hamostaseologie· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Cancer-Associated Thrombosis: An Update.
Minna Voigtlaender, Christina Rolling, Christina Hart

Hamostaseologie· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disorders of Thrombosis and Hemostasis in Cancer.
Christina Hart, Minna Voigtlaender

Hamostaseologie· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab for the Treatment of Acquired Hemophilia A: Consensus Recommendations from the GTH-AHA Working Group.
Christian Pfrepper, Robert Klamroth, Johannes Oldenburg, Katharina Holstein, Hermann Eichler, Christina Hart

Hamostaseologie· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiary.
Carmen Escuriola Ettingshausen, Wolfgang Eberl, Hermann Eichler, Ronald Fischer, Christina Hart

Ther Adv Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A.
Christina Hart, Robert Klamroth, Ulrich J Sachs, Richard Greil, Paul Knoebl

J Thromb Haemost· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies.
Markus Perl, Konstantin Herfeld, Dennis C Harrer, Matthias Höpting, Marina Schweiger, Christina Hart

Haematologica· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
Andreas Tiede, Christina Hart, Paul Knöbl, Richard Greil, Johannes Oldenburg

Lancet Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of bulk lipid species in human platelets and their thrombin-induced release.
Susanne Heimerl, Marcus Höring, Dominik Kopczynski, Alexander Sigruener, Christina Hart

Sci Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study.
Olga Oleshko, Sonja Werwitzke, Annika Klingberg, Torsten Witte, Hermann Eichler, Christina Hart

Blood Adv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Covid19 vaccination-associated portal vein thrombosis-An interdisciplinary clinical challenge.
Niklas Bogovic, Axel Doenecke, Christina Hart, Lukas Lürken, Susanne Heimerl

Clin Res Hepatol Gastroenterol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous Thromboembolism Issues in Women.
Birgit Linnemann, Hannelore Rott, Rainer Zotz, Christina Hart

Hamostaseologie· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Antithrombin Deficiency in Pregnancy.
Christina Hart, Hannelore Rott, Susanne Heimerl, Birgit Linnemann

Hamostaseologie· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women's Health Issues in Thrombosis and Haemostasis.
Birgit Linnemann, Christina Hart,

Hamostaseologie· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and outcomes of patients developing heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.
Matthias Lubnow, Johannes Berger, Roland Schneckenpointner, Florian Zeman, Dirk Lunz, Christina Hart

PLoS One· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient.
Matthias Höpting, Ulrich Budde, Andreas Tiede, Matthias Grube, Joachim Hahn, Christina Hart

Acta Haematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stanniocalcin 1 is overexpressed in multipotent mesenchymal stromal cells from acute myeloid leukemia patients.
Roland Christian Schelker, Andrea Kratzer, Gunnar Müller, Christoph Brochhausen, Christina Hart

Hematology· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Hormonal contraception and venous thromboembolism].
Christina Hart, Birgit Linnemann

Dtsch Med Wochenschr· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO).
Martin Kirschner, Nicole do Ó Hartmann, Stefani Parmentier, Christina Hart, Larissa Henze

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of Venous Thromboembolism during Pregnancy and the Puerperium with a Special Focus on Women with Hereditary Thrombophilia or Prior VTE-Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH).
Christina Hart, Rupert Bauersachs, Ute Scholz, Rainer Zotz, Frauke Bergmann

Hamostaseologie· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Thromboprophylaxis in ambulatory patients with cancer].
Christina Hart, Daniel Heudobler, Birgit Linnemann

Dtsch Med Wochenschr· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis